Biopharmaceutical company Kailera Therapeutics announced the appointment of Scott Akamine as chief legal officer.

Akamine joins Kailera from Cerevel Therapeutics where he served as chief legal officer and corporate secretary until the company’s acquisition by AbbVie in 2024.

Previously, he served as general counsel and corporate secretary of AEON Biopharma, as well as roles of increasing responsibility at Allergan until the company was acquired by Actavis.

Topics